August 24th, 2016
An agent of demise
Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Licensing
August 15th, 2016
Accelerating materials discovery
Harvard licenses powerful molecular screening platform to Kyulux, developer of OLED display technologies
March 21st, 2016
Blavatnik Biomedical Accelerator at Harvard University announces license and collaboration agreement
Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.
December 23rd, 2015
Targeting fat-tissue hormone may lead to type 2 diabetes treatment
UCB-funded Harvard study describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
